Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.bbrc.2020.11.021 http://scihub22266oqcxt.onion/10.1016/j.bbrc.2020.11.021 33218685!7657079!33218685     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biochem+Biophys+Res+Commun 2021 ; 538 (ä): 125-131 Nephropedia Template TP {{tp|p=33218685|t=2021. COVID19- clinical presentation and therapeutic considerations |pdf=|usr=}}{{33218685}} gab.com Text COVID19- clinical presentation and therapeutic considerations JO: Biochem Biophys Res Commun http://www.kidney.de/pget.php?&tw=1&pmid=33218685 #FOAvip The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic infection in 2020 has presented many therapeutic challenges. Not least among these is the importance of abnormal host response to infection that is one of the main drivers of more severe disease. Despite significant research endeavours, very few effective therapies have been identified, in part related to the different pathogenic mechanisms underlying different stages of clinical COVID-19. This mini review summarises data related to current and potential future therapies for COVID-19 and highlights the many challenges inherent in developing effective therapeutic options for new pandemic infection. Twit Text FOAVip COVID19- clinical presentation and therapeutic considerations ????Biochem Biophys Res Commun http://www.kidney.de/pget.php?&tw=1&pmid=33218685 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33218685 #FOAvip English Wikipedia <ref>{{Cite pmid|33218685}}</ref> COVID19- clinical presentation and therapeutic considerations #MMPMID33218685 Kenny G; Mallon PW Biochem Biophys Res Commun 2021[Jan]; 538 (ä): 125-131 PMID33218685show ga The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic infection in 2020 has presented many therapeutic challenges. Not least among these is the importance of abnormal host response to infection that is one of the main drivers of more severe disease. Despite significant research endeavours, very few effective therapies have been identified, in part related to the different pathogenic mechanisms underlying different stages of clinical COVID-19. This mini review summarises data related to current and potential future therapies for COVID-19 and highlights the many challenges inherent in developing effective therapeutic options for new pandemic infection. |*COVID-19 Drug Treatment[MESH] |*Pandemics[MESH] |*SARS-CoV-2[MESH] |Antiviral Agents/*therapeutic use[MESH]COVID19- clinical presentation and therapeutic considerations (epmc).pdf DeepDyve Pubget Overpricing